Amlodipine Besylate Tablets Market, Global Outlook and Forecast 2022-2028

Publisher Name :
Date: 26-Feb-2022
No. of pages: 78

Amlodipine besylate is a dihydropyridine calcium channel antagonist, which can selectively inhibit cell membrane calcium ion channels, act on smooth muscle cells and cardiomyocytes, effectively regulate intracellular calcium levels, and enable normal physiological functions. Maintain, thereby dilate the coronary blood vessels and the blood vessels of the whole body, and lower blood pressure. Clinically, it is generally used to treat hypertensive coronary heart disease and essential hypertension. Amlodipine can be used alone or in combination with other antihypertensive drugs, chronic stable angina and variant angina.

This report contains market size and forecasts of Amlodipine Besylate Tablets in global, including the following market information:

Global Amlodipine Besylate Tablets Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Amlodipine Besylate Tablets Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Amlodipine Besylate Tablets companies in 2021 (%)

The global Amlodipine Besylate Tablets market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

5 Milligrams Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Amlodipine Besylate Tablets include China Resources Double-Crane Pharmaceutical, Pfizer, North China Pharmaceutical, AstraZeneca, Sanofi, Roche, Bristol-Myers Squibb, Yangtze River Pharmaceutical and Shanghai Shyndec Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Amlodipine Besylate Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Amlodipine Besylate Tablets Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Amlodipine Besylate Tablets Market Segment Percentages, by Type, 2021 (%)

- 5 Milligrams

- 10 Milligrams

Global Amlodipine Besylate Tablets Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Amlodipine Besylate Tablets Market Segment Percentages, by Application, 2021 (%)

- Hospital

- Pharmacy

Global Amlodipine Besylate Tablets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Amlodipine Besylate Tablets Market Segment Percentages, By Region and Country, 2021 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Amlodipine Besylate Tablets revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Amlodipine Besylate Tablets revenues share in global market, 2021 (%)

Key companies Amlodipine Besylate Tablets sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Amlodipine Besylate Tablets sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

- China Resources Double-Crane Pharmaceutical

- Pfizer

- North China Pharmaceutical

- AstraZeneca

- Sanofi

- Roche

- Bristol-Myers Squibb

- Yangtze River Pharmaceutical

- Shanghai Shyndec Pharmaceutical

- Jingfeng Pharmaceutical

Amlodipine Besylate Tablets Market, Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Amlodipine Besylate Tablets Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Amlodipine Besylate Tablets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Amlodipine Besylate Tablets Overall Market Size
2.1 Global Amlodipine Besylate Tablets Market Size: 2021 VS 2028
2.2 Global Amlodipine Besylate Tablets Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Amlodipine Besylate Tablets Sales: 2017-2028
3 Company Landscape
3.1 Top Amlodipine Besylate Tablets Players in Global Market
3.2 Top Global Amlodipine Besylate Tablets Companies Ranked by Revenue
3.3 Global Amlodipine Besylate Tablets Revenue by Companies
3.4 Global Amlodipine Besylate Tablets Sales by Companies
3.5 Global Amlodipine Besylate Tablets Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Amlodipine Besylate Tablets Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Amlodipine Besylate Tablets Product Type
3.8 Tier 1, Tier 2 and Tier 3 Amlodipine Besylate Tablets Players in Global Market
3.8.1 List of Global Tier 1 Amlodipine Besylate Tablets Companies
3.8.2 List of Global Tier 2 and Tier 3 Amlodipine Besylate Tablets Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Amlodipine Besylate Tablets Market Size Markets, 2021 & 2028
4.1.2 5 Milligrams
4.1.3 10 Milligrams
4.2 By Type - Global Amlodipine Besylate Tablets Revenue & Forecasts
4.2.1 By Type - Global Amlodipine Besylate Tablets Revenue, 2017-2022
4.2.2 By Type - Global Amlodipine Besylate Tablets Revenue, 2023-2028
4.2.3 By Type - Global Amlodipine Besylate Tablets Revenue Market Share, 2017-2028
4.3 By Type - Global Amlodipine Besylate Tablets Sales & Forecasts
4.3.1 By Type - Global Amlodipine Besylate Tablets Sales, 2017-2022
4.3.2 By Type - Global Amlodipine Besylate Tablets Sales, 2023-2028
4.3.3 By Type - Global Amlodipine Besylate Tablets Sales Market Share, 2017-2028
4.4 By Type - Global Amlodipine Besylate Tablets Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Amlodipine Besylate Tablets Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application - Global Amlodipine Besylate Tablets Revenue & Forecasts
5.2.1 By Application - Global Amlodipine Besylate Tablets Revenue, 2017-2022
5.2.2 By Application - Global Amlodipine Besylate Tablets Revenue, 2023-2028
5.2.3 By Application - Global Amlodipine Besylate Tablets Revenue Market Share, 2017-2028
5.3 By Application - Global Amlodipine Besylate Tablets Sales & Forecasts
5.3.1 By Application - Global Amlodipine Besylate Tablets Sales, 2017-2022
5.3.2 By Application - Global Amlodipine Besylate Tablets Sales, 2023-2028
5.3.3 By Application - Global Amlodipine Besylate Tablets Sales Market Share, 2017-2028
5.4 By Application - Global Amlodipine Besylate Tablets Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Amlodipine Besylate Tablets Market Size, 2021 & 2028
6.2 By Region - Global Amlodipine Besylate Tablets Revenue & Forecasts
6.2.1 By Region - Global Amlodipine Besylate Tablets Revenue, 2017-2022
6.2.2 By Region - Global Amlodipine Besylate Tablets Revenue, 2023-2028
6.2.3 By Region - Global Amlodipine Besylate Tablets Revenue Market Share, 2017-2028
6.3 By Region - Global Amlodipine Besylate Tablets Sales & Forecasts
6.3.1 By Region - Global Amlodipine Besylate Tablets Sales, 2017-2022
6.3.2 By Region - Global Amlodipine Besylate Tablets Sales, 2023-2028
6.3.3 By Region - Global Amlodipine Besylate Tablets Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Amlodipine Besylate Tablets Revenue, 2017-2028
6.4.2 By Country - North America Amlodipine Besylate Tablets Sales, 2017-2028
6.4.3 US Amlodipine Besylate Tablets Market Size, 2017-2028
6.4.4 Canada Amlodipine Besylate Tablets Market Size, 2017-2028
6.4.5 Mexico Amlodipine Besylate Tablets Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Amlodipine Besylate Tablets Revenue, 2017-2028
6.5.2 By Country - Europe Amlodipine Besylate Tablets Sales, 2017-2028
6.5.3 Germany Amlodipine Besylate Tablets Market Size, 2017-2028
6.5.4 France Amlodipine Besylate Tablets Market Size, 2017-2028
6.5.5 U.K. Amlodipine Besylate Tablets Market Size, 2017-2028
6.5.6 Italy Amlodipine Besylate Tablets Market Size, 2017-2028
6.5.7 Russia Amlodipine Besylate Tablets Market Size, 2017-2028
6.5.8 Nordic Countries Amlodipine Besylate Tablets Market Size, 2017-2028
6.5.9 Benelux Amlodipine Besylate Tablets Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Amlodipine Besylate Tablets Revenue, 2017-2028
6.6.2 By Region - Asia Amlodipine Besylate Tablets Sales, 2017-2028
6.6.3 China Amlodipine Besylate Tablets Market Size, 2017-2028
6.6.4 Japan Amlodipine Besylate Tablets Market Size, 2017-2028
6.6.5 South Korea Amlodipine Besylate Tablets Market Size, 2017-2028
6.6.6 Southeast Asia Amlodipine Besylate Tablets Market Size, 2017-2028
6.6.7 India Amlodipine Besylate Tablets Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Amlodipine Besylate Tablets Revenue, 2017-2028
6.7.2 By Country - South America Amlodipine Besylate Tablets Sales, 2017-2028
6.7.3 Brazil Amlodipine Besylate Tablets Market Size, 2017-2028
6.7.4 Argentina Amlodipine Besylate Tablets Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Amlodipine Besylate Tablets Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Amlodipine Besylate Tablets Sales, 2017-2028
6.8.3 Turkey Amlodipine Besylate Tablets Market Size, 2017-2028
6.8.4 Israel Amlodipine Besylate Tablets Market Size, 2017-2028
6.8.5 Saudi Arabia Amlodipine Besylate Tablets Market Size, 2017-2028
6.8.6 UAE Amlodipine Besylate Tablets Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 China Resources Double-Crane Pharmaceutical
7.1.1 China Resources Double-Crane Pharmaceutical Corporate Summary
7.1.2 China Resources Double-Crane Pharmaceutical Business Overview
7.1.3 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Major Product Offerings
7.1.4 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales and Revenue in Global (2017-2022)
7.1.5 China Resources Double-Crane Pharmaceutical Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Amlodipine Besylate Tablets Major Product Offerings
7.2.4 Pfizer Amlodipine Besylate Tablets Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer Key News
7.3 North China Pharmaceutical
7.3.1 North China Pharmaceutical Corporate Summary
7.3.2 North China Pharmaceutical Business Overview
7.3.3 North China Pharmaceutical Amlodipine Besylate Tablets Major Product Offerings
7.3.4 North China Pharmaceutical Amlodipine Besylate Tablets Sales and Revenue in Global (2017-2022)
7.3.5 North China Pharmaceutical Key News
7.4 AstraZeneca
7.4.1 AstraZeneca Corporate Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Amlodipine Besylate Tablets Major Product Offerings
7.4.4 AstraZeneca Amlodipine Besylate Tablets Sales and Revenue in Global (2017-2022)
7.4.5 AstraZeneca Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Amlodipine Besylate Tablets Major Product Offerings
7.5.4 Sanofi Amlodipine Besylate Tablets Sales and Revenue in Global (2017-2022)
7.5.5 Sanofi Key News
7.6 Roche
7.6.1 Roche Corporate Summary
7.6.2 Roche Business Overview
7.6.3 Roche Amlodipine Besylate Tablets Major Product Offerings
7.6.4 Roche Amlodipine Besylate Tablets Sales and Revenue in Global (2017-2022)
7.6.5 Roche Key News
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Corporate Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Amlodipine Besylate Tablets Major Product Offerings
7.7.4 Bristol-Myers Squibb Amlodipine Besylate Tablets Sales and Revenue in Global (2017-2022)
7.7.5 Bristol-Myers Squibb Key News
7.8 Yangtze River Pharmaceutical
7.8.1 Yangtze River Pharmaceutical Corporate Summary
7.8.2 Yangtze River Pharmaceutical Business Overview
7.8.3 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Major Product Offerings
7.8.4 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales and Revenue in Global (2017-2022)
7.8.5 Yangtze River Pharmaceutical Key News
7.9 Shanghai Shyndec Pharmaceutical
7.9.1 Shanghai Shyndec Pharmaceutical Corporate Summary
7.9.2 Shanghai Shyndec Pharmaceutical Business Overview
7.9.3 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Major Product Offerings
7.9.4 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales and Revenue in Global (2017-2022)
7.9.5 Shanghai Shyndec Pharmaceutical Key News
7.10 Jingfeng Pharmaceutical
7.10.1 Jingfeng Pharmaceutical Corporate Summary
7.10.2 Jingfeng Pharmaceutical Business Overview
7.10.3 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Major Product Offerings
7.10.4 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales and Revenue in Global (2017-2022)
7.10.5 Jingfeng Pharmaceutical Key News
8 Global Amlodipine Besylate Tablets Production Capacity, Analysis
8.1 Global Amlodipine Besylate Tablets Production Capacity, 2017-2028
8.2 Amlodipine Besylate Tablets Production Capacity of Key Manufacturers in Global Market
8.3 Global Amlodipine Besylate Tablets Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Amlodipine Besylate Tablets Supply Chain Analysis
10.1 Amlodipine Besylate Tablets Industry Value Chain
10.2 Amlodipine Besylate Tablets Upstream Market
10.3 Amlodipine Besylate Tablets Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Amlodipine Besylate Tablets Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Amlodipine Besylate Tablets in Global Market
Table 2. Top Amlodipine Besylate Tablets Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Amlodipine Besylate Tablets Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Amlodipine Besylate Tablets Revenue Share by Companies, 2017-2022
Table 5. Global Amlodipine Besylate Tablets Sales by Companies, (K Units), 2017-2022
Table 6. Global Amlodipine Besylate Tablets Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Amlodipine Besylate Tablets Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Amlodipine Besylate Tablets Product Type
Table 9. List of Global Tier 1 Amlodipine Besylate Tablets Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Amlodipine Besylate Tablets Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Amlodipine Besylate Tablets Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Amlodipine Besylate Tablets Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Amlodipine Besylate Tablets Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Amlodipine Besylate Tablets Sales (K Units), 2017-2022
Table 15. By Type - Global Amlodipine Besylate Tablets Sales (K Units), 2023-2028
Table 16. By Application - Global Amlodipine Besylate Tablets Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Amlodipine Besylate Tablets Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Amlodipine Besylate Tablets Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Amlodipine Besylate Tablets Sales (K Units), 2017-2022
Table 20. By Application - Global Amlodipine Besylate Tablets Sales (K Units), 2023-2028
Table 21. By Region - Global Amlodipine Besylate Tablets Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Amlodipine Besylate Tablets Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Amlodipine Besylate Tablets Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Amlodipine Besylate Tablets Sales (K Units), 2017-2022
Table 25. By Region - Global Amlodipine Besylate Tablets Sales (K Units), 2023-2028
Table 26. By Country - North America Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Amlodipine Besylate Tablets Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Amlodipine Besylate Tablets Sales, (K Units), 2017-2022
Table 29. By Country - North America Amlodipine Besylate Tablets Sales, (K Units), 2023-2028
Table 30. By Country - Europe Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Amlodipine Besylate Tablets Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Amlodipine Besylate Tablets Sales, (K Units), 2017-2022
Table 33. By Country - Europe Amlodipine Besylate Tablets Sales, (K Units), 2023-2028
Table 34. By Region - Asia Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Amlodipine Besylate Tablets Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Amlodipine Besylate Tablets Sales, (K Units), 2017-2022
Table 37. By Region - Asia Amlodipine Besylate Tablets Sales, (K Units), 2023-2028
Table 38. By Country - South America Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Amlodipine Besylate Tablets Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Amlodipine Besylate Tablets Sales, (K Units), 2017-2022
Table 41. By Country - South America Amlodipine Besylate Tablets Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Amlodipine Besylate Tablets Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Amlodipine Besylate Tablets Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Amlodipine Besylate Tablets Sales, (K Units), 2023-2028
Table 46. China Resources Double-Crane Pharmaceutical Corporate Summary
Table 47. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product Offerings
Table 48. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Amlodipine Besylate Tablets Product Offerings
Table 51. Pfizer Amlodipine Besylate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. North China Pharmaceutical Corporate Summary
Table 53. North China Pharmaceutical Amlodipine Besylate Tablets Product Offerings
Table 54. North China Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. AstraZeneca Corporate Summary
Table 56. AstraZeneca Amlodipine Besylate Tablets Product Offerings
Table 57. AstraZeneca Amlodipine Besylate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Sanofi Corporate Summary
Table 59. Sanofi Amlodipine Besylate Tablets Product Offerings
Table 60. Sanofi Amlodipine Besylate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Roche Corporate Summary
Table 62. Roche Amlodipine Besylate Tablets Product Offerings
Table 63. Roche Amlodipine Besylate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Bristol-Myers Squibb Corporate Summary
Table 65. Bristol-Myers Squibb Amlodipine Besylate Tablets Product Offerings
Table 66. Bristol-Myers Squibb Amlodipine Besylate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Yangtze River Pharmaceutical Corporate Summary
Table 68. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product Offerings
Table 69. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Shanghai Shyndec Pharmaceutical Corporate Summary
Table 71. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product Offerings
Table 72. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Jingfeng Pharmaceutical Corporate Summary
Table 74. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product Offerings
Table 75. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Amlodipine Besylate Tablets Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Amlodipine Besylate Tablets Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Amlodipine Besylate Tablets Production by Region, 2017-2022 (K Units)
Table 79. Global Amlodipine Besylate Tablets Production by Region, 2023-2028 (K Units)
Table 80. Amlodipine Besylate Tablets Market Opportunities & Trends in Global Market
Table 81. Amlodipine Besylate Tablets Market Drivers in Global Market
Table 82. Amlodipine Besylate Tablets Market Restraints in Global Market
Table 83. Amlodipine Besylate Tablets Raw Materials
Table 84. Amlodipine Besylate Tablets Raw Materials Suppliers in Global Market
Table 85. Typical Amlodipine Besylate Tablets Downstream
Table 86. Amlodipine Besylate Tablets Downstream Clients in Global Market
Table 87. Amlodipine Besylate Tablets Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Amlodipine Besylate Tablets Segment by Type
Figure 2. Amlodipine Besylate Tablets Segment by Application
Figure 3. Global Amlodipine Besylate Tablets Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Amlodipine Besylate Tablets Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Amlodipine Besylate Tablets Revenue, 2017-2028 (US$, Mn)
Figure 7. Amlodipine Besylate Tablets Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Amlodipine Besylate Tablets Revenue in 2021
Figure 9. By Type - Global Amlodipine Besylate Tablets Sales Market Share, 2017-2028
Figure 10. By Type - Global Amlodipine Besylate Tablets Revenue Market Share, 2017-2028
Figure 11. By Type - Global Amlodipine Besylate Tablets Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Amlodipine Besylate Tablets Sales Market Share, 2017-2028
Figure 13. By Application - Global Amlodipine Besylate Tablets Revenue Market Share, 2017-2028
Figure 14. By Application - Global Amlodipine Besylate Tablets Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Amlodipine Besylate Tablets Sales Market Share, 2017-2028
Figure 16. By Region - Global Amlodipine Besylate Tablets Revenue Market Share, 2017-2028
Figure 17. By Country - North America Amlodipine Besylate Tablets Revenue Market Share, 2017-2028
Figure 18. By Country - North America Amlodipine Besylate Tablets Sales Market Share, 2017-2028
Figure 19. US Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Amlodipine Besylate Tablets Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Amlodipine Besylate Tablets Sales Market Share, 2017-2028
Figure 24. Germany Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 25. France Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Amlodipine Besylate Tablets Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Amlodipine Besylate Tablets Sales Market Share, 2017-2028
Figure 33. China Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 37. India Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Amlodipine Besylate Tablets Revenue Market Share, 2017-2028
Figure 39. By Country - South America Amlodipine Besylate Tablets Sales Market Share, 2017-2028
Figure 40. Brazil Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Amlodipine Besylate Tablets Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Amlodipine Besylate Tablets Sales Market Share, 2017-2028
Figure 44. Turkey Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Amlodipine Besylate Tablets Revenue, (US$, Mn), 2017-2028
Figure 48. Global Amlodipine Besylate Tablets Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Amlodipine Besylate Tablets by Region, 2021 VS 2028
Figure 50. Amlodipine Besylate Tablets Industry Value Chain
Figure 51. Marketing Channels
  • Global Digoxin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 75
    According to our LPI (LP Information) latest study, the global Digoxin market size was valued at US$ 59 million in 2023. With growing demand in downstream market, the Digoxin is forecast to a readjusted size of US$ 73 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Digoxin market. Digoxin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain op......
  • Global Heart Failure Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Heart Failure Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Heart Failure Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Heart Failure Drugs market. Heart Failure Drugs are expected to show stable growth in the future market. However, product differentiatio......
  • Global Atorvastatin Calcium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138
    According to our LPI (LP Information) latest study, the global Atorvastatin Calcium market size was valued at US$ 214.2 million in 2023. With growing demand in downstream market, the Atorvastatin Calcium is forecast to a readjusted size of US$ 362 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Atorvastatin Calcium market. Atorvastatin Calcium are expected to show stable growth in the future market. However, prod......
  • Global Rosuvastatin Calcium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139
    According to our LPI (LP Information) latest study, the global Rosuvastatin Calcium market size was valued at US$ 514.3 million in 2023. With growing demand in downstream market, the Rosuvastatin Calcium is forecast to a readjusted size of US$ 683.6 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Rosuvastatin Calcium market. Rosuvastatin Calcium are expected to show stable growth in the future market. However, pr......
  • Global Atorvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 133
    According to our (Global Info Research) latest study, the global Atorvastatin Calcium market size was valued at USD 225.3 million in 2023 and is forecast to a readjusted size of USD 366.1 million by 2030 with a CAGR of 7.2% during review period. Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL choleste......
  • Global Rosuvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132
    According to our (Global Info Research) latest study, the global Rosuvastatin Calcium market size was valued at USD 540.9 million in 2023 and is forecast to a readjusted size of USD 703.6 million by 2030 with a CAGR of 3.8% during review period. Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart att......
  • Cilostazol - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118
    The global Cilostazol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cilostazol in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Cilostazol market. Injection Cilostazol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-dried P......
  • Rosuvastatin - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 110
    Rosuvastatin medication is a statin that is used to lower bad cholesterol and prevent cardiovascular disease. It works by blocking an enzyme in the liver that makes cholesterol. It is taken by mouth and should be used together with dietary changes, exercise, and weight loss. It may also raise good cholesterol and lower triglycerides. It is sold under the brand name Crestor among others. It may be used when other statins have not worked well. The global Rosuvastatin market size is expected......
  • Global Congestive Heart Failure Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Congestive Heart Failure Drugs market: According to our latest research, the global Congestive Heart Failure Drugs market looks promising in the next 5 years. As of 2022, the global Congestive Heart Failure Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Congestive heart failure is a serious and complex condition in which the heart muscles are either dam......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs